Results from the prospective German TPK clinical cohort study: Treatment algorithms and survival of 1,174 patients with locally advanced, inoperable, or metastatic pancreatic ductal adenocarcinoma

Author:

Hegewisch-Becker Susanna1,Aldaoud Ali2,Wolf Thomas3,Krammer-Steiner Beate4,Linde Hartmut5,Scheiner-Sparna Renate6,Hamm David7,Jänicke Martina7,Marschner Norbert8ORCID,

Affiliation:

1. HOPE-Practice for Oncology; Hamburg Germany

2. HELIOS Park-Klinikum; Pankreaszentrum, Leipzig Germany

3. Outpatient Centre for Oncology; Dresden Germany

4. Rostock South City Medical Centre; Rostock Germany

5. Ambulatory Healthcare Centre for Cancer and Blood Diseases; Potsdam Germany

6. Statistics, iOMEDICO; Freiburg Germany

7. Clinical Epidemiology and Health Economics; iOMEDICO; Freiburg Germany

8. Outpatient-Centre for Interdisciplinary Oncology and Haematology; Freiburg Germany

Funder

Baxter Deutschland GmbH

Celgene GmbH

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res,2014

2. Robert-Koch-Institut Zentrum für Krebsregisterdaten im RK-I Bericht zum Krebsgeschehen in Deutschland 2016 2016

3. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J Clin Oncol Off J Am Soc Clin Oncol,1997

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3